About CoreRx
CoreRx is a Healthcare company based in Clearwater (United States) founded in 2006, and was acquired by NovaQuest Capital Management in January 2021. CDMO with a focus on early phase drug product development. CoreRx has raised $15 million across 4 funding rounds from investors including Florida High Tech Corridor, Signet Healthcare Partners and NovaQuest Capital Management. CoreRx has completed 1 acquisition, including Societal CDMO. Its Indian entity Corerx Pharma India Private Limited reported revenue of ₹4.94 Cr. CoreRx offers products and services including Drug Delivery Platforms, Particle Engineering, and Solid Dosage Forms. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation.
Company details
CoreRx was founded in 2006 in Clearwater, United States, as a contract development and manufacturing organization in the pharmaceutical sector. A range of cGMP-compliant services is offered, including pre-formulation, analytical development, product formulation, and clinical manufacturing. Support is provided for solid oral dosage forms, semi-solids, liquids, and API packaging. Operations focus on accelerating entry into clinical trials through certified facilities and technical services.
- Headquarters Clearwater, United States
- Stage Acquired
- SectorsHealthcare
- Website corerxpharma.com
- Social LinkedIn
- Acquired by NovaQuest Capital Management (Jan 2021)
- Legal Name Corerx Pharma India Private Limited
- Date of Incorporation 13 May, 2021
- Jurisdiction Bangalore, Karnataka, India
- Indian entity revenue₹4.94 Cr
FY 2025 · +11% YoY
- Indian entity net profit₹22.6 Lakh
FY 2025 · 5% margin
- Indian entity EBITDA₹42.5 Lakh
FY 2025 · 9% margin
- Total Equity Funding$15M (USD)
in 4 rounds
- Latest Funding Round$3M (USD), Series A
Mar 2019
- InvestorsFlorida High Tech Corridor
& 2 more
- Investments & Acquisitions
- Acquired byNovaQuest Capital Management
(Jan 2021)
Associated legal entities of CoreRx
CoreRx operates through Corerx Pharma India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Corerx Pharma India Private Limited CIN U24304KA2021FTC147384 | Active | 13 May 2021 | Bangalore, Karnataka | ₹4.9 Cr | 21 | 2 | View details |
Products & Services of CoreRx
CoreRx offers a comprehensive portfolio of products and services, including Drug Delivery Platforms, Particle Engineering, and Solid Dosage Forms.
Develops and commercializes particle-based drug delivery systems
Engineers solutions for inhaled and bioavailability-enhanced drugs
Produces intermediate and modified release formulations
Funding Insights of CoreRx
CoreRx has successfully raised a total of $15M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $3 million completed in March 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $15M
- Total Rounds 4
- Last Round Series A — $3M
- First Round $200,000
(Jun 2013)
- Investors Count 2
All 4 funding rounds of CoreRx with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2019 | $3M | Series A | – | – | – |
| Apr 2017 | $5M | Series A | – | – | – |
| Mar 2015 | $7M | Series A | – | Signet Healthcare Partners | – |
| Jun 2013 | $200,000 | Grant | – | – |
3 investors in total: 3 institutional.
Investors in CoreRx
CoreRx has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Florida High Tech Corridor, Signet Healthcare Partners and NovaQuest Capital Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
PE firm investing in North America and Europe | signethealthcarepartners.com | New York, United States | ||
PE firm focused on life science and healthcare companies | novaquest.com | Raleigh, United States | ||
The Florida High Tech Corridor is focused on regional high-tech development. | floridahightech.com | United States |
Investor details for CoreRx
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Corerx Pharma India Private Limited (CoreRx)
Corerx Pharma India Private Limited is the primary company behind CoreRx. The board of Corerx Pharma India Private Limited currently have 2 directors; the longest-serving is Jayesh Patel, appointed in 2021.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Jayesh Patel DIN 08467186 | Director | 13 May 2021 | 5 yrs 6 mo | Corerx Pharma India Private Limited |
| Aniket Padmakar Manathkar DIN 09172789 | Director | 13 May 2021 | 5 yrs 6 mo | Corerx Pharma India Private Limited |
People of CoreRx
43 people are tracked at CoreRx (9 in leadership, 34 in team).
| Name | Role | Group |
|---|---|---|
David Vodak | Chief Science Officer | Leadership |
Leanne Ryan | Senior Director, Associate General Counsel | Leadership |
Brenda Simpson | Director of Business Development | Leadership |
David Fish | Warehouse Director | Leadership |
Fawn L. | Chief Financial Officer | Leadership |
Kevin Rierson, SHRM-CP | Executive Director of Human Resources | Leadership |
| General Manager | Leadership | |
Scott Bone | Director of Formulation Science | Leadership |
Anders Forsell | Chief Financial Officer | Leadership |
Navya Nayak | Inside Sales Executive | Team |
Kevin Cloud | Senior Scientist | Team |
Brian Perrow | Facilities Manager | Team |
Mike Favero | Formulations Scientist at CoreRx Pharmaceuticals | Team |
Josh Miller | Formulation Scientist | Team |
Enxhi Koroni | Scientist II | Team |
Jejuan Maxwell | Research Associate | Team |
Matthew Gross | Laboratory Software Systems Administrator | Team |
Sean Ronning | Inventory Control Manager | Team |
Kristen LeBlanc | Analytical Scientist III | Team |
Vittal Mallegave | Executive inside sales | Team |
23 more people are available in the full profile.
Complete people profiles for CoreRx
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of CoreRx
Figures of Corerx Pharma India Private Limited, the primary company behind CoreRx, for FY 2025. Revenue was ₹4.94 Cr (+11% year on year). Net profit was ₹22.6 Lakh (5% margin). EBITDA was ₹42.5 Lakh (9% margin). Revenue has grown at a compounded annual rate of +61% over three years.
- ₹4.94 CrRevenue · FY 2025 · +11% YoY
- ₹22.6 LakhNet profit · 5% margin
- ₹42.5 LakhEBITDA · 9% margin
- ₹1 LakhPaid-up capital
- 21Employees (provident fund records)
- +61%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Corerx Pharma India Private Limited are on its company page.
Detailed financial statements for CoreRx
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CoreRx
CoreRx has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Societal CDMO.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Provider of clinical trial, formulation development, packaging, and quality assurance services | societalcdmo.com | San Diego, United States | 1982 | Feb 2024 | •••• |
Complete acquisition details for CoreRx
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of CoreRx
5 dated milestones of CoreRx across 18 years, from founding to its latest funding, stage changes and deals.
- Founded CoreRx is founded.
- Funding First funding round of $200K.
- Funding Latest funding round, Series A, of $3.0M.
- Exit Acquired by NovaQuest Capital Management.
- Acquisition Acquires Societal CDMO.
Web traffic of CoreRx
Websites that share an audience with CoreRx (corerxpharma.com).
Websites whose visitors overlap most with CoreRx. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| pharmatek.com | 100% | View details | |||
| irisys.com | 99% | View details | |||
| therapurebio.com | 99% | View details | |||
| ropack.com | 98% | #8,296,511 | View details | ||
| contractpharma.com | 98% | 67.7K | #631,663 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for CoreRx
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as CoreRx (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Corerx
Complete news archive for CoreRx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CoreRx
CoreRx was founded in 2006 and raised its 1st funding round 7 years after it was founded.
CoreRx is headquartered in Clearwater, United States. It is registered at Clearwater, Florida, United States.
CoreRx is a funded company, having raised a total of $15M across 4 funding rounds to date. The company's 1st funding round was a Grant of $200K, raised on Jun 2013.
The primary company behind CoreRx, Corerx Pharma India Private Limited, reported revenue of ₹4.94 Cr for FY 2025, up 11% year on year.
CoreRx was founded in 2006 in Clearwater, United States, as a contract development and manufacturing organization in the pharmaceutical sector. A range of cGMP-compliant services is offered, including pre-formulation, analytical development, product formulation, and clinical manufacturing. Support is provided for solid oral dosage forms, semi-solids, liquids, and API packaging. Operations focus on accelerating entry into clinical trials through certified facilities and technical services.
CoreRx offers Drug Delivery Platforms, Particle Engineering, and Solid Dosage Forms.
CoreRx has made 1 acquisition, including Societal CDMO.
CoreRx has 3 investors. Key investors include Florida High Tech Corridor, Signet Healthcare Partners, and NovaQuest Capital Management.
CoreRx operates through Corerx Pharma India Private Limited.
Yes. CoreRx was acquired by NovaQuest Capital Management in January 2021.
The legal entities of CoreRx currently have 2 directors, including Jayesh Patel, Aniket Padmakar Manathkar.